...BRCA2 mutations are less common than BRCA1 mutations in ovarian cancer families. A high proportion of serous adenocarcin...
...BRCA2 germline mutations.,We conducted a randomized, double-blind, placebo-controlled, phase 2 study to evaluate mainten...
...BRCA2 (P = 0·0072) and FANCF (P = 0·0458) mRNA following bortezomib treatment. Bortezomib combined with high-dose melpha...
...BRCA2 in breast cancer and MSH2, MSH6, MLH1, and PSM2 in hereditary nonpolyposis colorectal cancer (HNPCC, more recently...
The success of poly(ADP-ribose) polymerase inhibition in BRCA1 or BRCA2 deficient tumors as an anticancer strategy provi...
...BRCA2 genes. However, many families with breast cancer predisposition do not carry any known mutations for BRCA1 and BRC...
...BRCA2 has been completed, with globally negative results.,The genomic region of SLX4, comprising all exons and exon-intr...
...BRCA2 (8765delAG). A few additional recurring mutations [A1708E, 981delAT, C61G (BRCA1) R2336P, and IVS2 + 1G > A (BRCA2...
...BRCA2 function in a complex gene network that regulates homologous recombination and DNA double-strand break repair. Dis...
...BRCA2 mutations, and 23 women had no mutations. For the entire group, the 5-year local recurrence-free survival rate was...
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com